drugset
drugset / Trial / NCT06996184

Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults

NCT06996184 ↗

Phase 1 Completed 28 enrolled CSL Behring
RandomizedCrossoverOpen-labelOther

Summary

This is a phase I, single-center, randomized, open-label, single-dose, 2-way, 2-period, crossover study to evaluate the effect of food on the pharmacokinetics (PK) of vamifeport prolonged-release (PR) formulation in healthy adult participants. Participants will be randomly allocated to one of two treatment sequences.

Timeline

Start
2025-05-27
Primary completion
2025-07-01
Completion
2025-07-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vamifeport Small molecule — Oral

Indications

No indication recorded.